-+ 0.00%
-+ 0.00%
-+ 0.00%

Arcadia Biosciences Q2 FY26 net loss widens 41% to $6.27 million; revenue slips 1% to $1.44 million

PUBT·08/13/2026 20:13:00
Listen to the news
Arcadia Biosciences Q2 FY26 net loss widens 41% to $6.27 million; revenue slips 1% to $1.44 million
  • Arcadia Biosciences posted Q2 net loss attributable to common stockholders of USD 6.27 million, worsening 41% year over year.
  • Revenue slipped 1% to USD 1.44 million, while operating loss narrowed to USD 496,000 from USD 501,000.
  • First-half net loss attributable to common stockholders widened to USD 10.65 million from USD 1.86 million.
  • Six-month revenue fell 4% to USD 2.54 million on low inventory balances and longer-than-expected shipping times.
  • Ended Q2 with USD 4.2 million cash after a USD 4 million private placement; July Zola sales topped USD 740,000.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608131605PRIMZONEFULLFEED9809585) on August 13, 2026, and is solely responsible for the information contained therein.